[1]
Ghosh, MD, DM, A., Naskar, MD, C., Roub, MD, DM, F.- e and Basu, MD, DNB, MAMS, D. 2021. Review of the adaptations in opioid agonist treatment during the COVID-19 pandemic: Focus on buprenorphine-based treatment. Journal of Opioid Management. 17, 7 (Aug. 2021), 119–131. DOI:https://doi.org/10.5055/jom.2021.0649.